Lu Daopei Medical Group
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
Lu Daopei Medical Group - overview
Established
2001
Location
Beijing, -, China
Primary Industry
Healthcare
About
Founded in 2001 and based in Beijing, China, Lu Daopei Medical Group operates a chain of medical institutions that focuses on research and development (R&D) of blood diseases and hematopoietic stem cell transplantation. Lu Daopei Medical Group also provides medical services and treatments on diseases such as lymphoma, myeloma, and other hematology diseases. The founder of the company is Dr. Daopei Lu, who is also the founder of the Institute of Hematology at Peking University.
Current Investors
Investcorp, Hillhouse Investment, CBC Group
Primary Industry
Healthcare
Sub Industries
Biotechnology, Clinics/Outpatient Services, Healthcare Specialists, Pharmaceuticals
Website
www.daopei.net
Company Stage
Mature
Total Amount Raised
Subscriber access only
Lu Daopei Medical Group - deals
| Deals Type | Deal Status | Target (s) | Deal Date | Investor(s) | Seller(s) | Deal size (Mn) | Enterprise value (Mn) | Post-money valuation (Mn) | EBITDA multiple (x) | Revenue multiple (x) | Lead partner (s) |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Secondary Buyout | Completed | Lu Daopei Medical Group | - |
Displaying 1 - 1 of 1
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.